These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35001607)

  • 1. Severe autoimmune hepatitis following recovery from COVID-19: a novel mode of liver injury triggered by SARS-COV-2?
    Folman A; Said-Ahmad H; Mari A; Saadi T; Veitsman E; Yaccob A
    Minerva Gastroenterol (Torino); 2022 Sep; 68(3):334-336. PubMed ID: 35001607
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study.
    Lee SK; Kwon JH; Yoon N; Nam SW; Sung PS
    Clin Mol Hepatol; 2022 Oct; 28(4):926-928. PubMed ID: 36064307
    [No Abstract]   [Full Text] [Related]  

  • 3. Untouched.
    Ray A
    Lancet Respir Med; 2021 Mar; 9(3):234-235. PubMed ID: 33493451
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 and autoimmune hepatitis onset: a new association.
    Durazzo M; Ferro A
    Minerva Gastroenterol (Torino); 2022 Sep; 68(3):259-260. PubMed ID: 36083103
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    Vuille-Lessard É; Montani M; Bosch J; Semmo N
    J Autoimmun; 2021 Sep; 123():102710. PubMed ID: 34332438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
    Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
    United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury.
    Lleo A; Cazzagon N; Rigamonti C; Cabibbo G; Lai Q; Muratori L; Carbone M;
    Dig Liver Dis; 2022 Jun; 54(6):722-726. PubMed ID: 35410851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hepatitis triggered by COVID-19: A report of two cases.
    Kabaçam G; Wahlin S; Efe C
    Liver Int; 2021 Oct; 41(10):2527-2528. PubMed ID: 34478591
    [No Abstract]   [Full Text] [Related]  

  • 9. First report of post-transplant autoimmune hepatitis recurrence following SARS-CoV-2 mRNA vaccination.
    Mahalingham A; Duckworth A; Griffiths WJH
    Transpl Immunol; 2022 Jun; 72():101600. PubMed ID: 35390478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality.
    Rocco A; Sgamato C; Compare D; Nardone G
    J Hepatol; 2021 Sep; 75(3):728-729. PubMed ID: 34116081
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune Hepatitis Associated with COVID-19 Infection - A Diagnostic and Therapeutic Dilemma.
    Rajendiran G; Cowman B; Erickson K; Oliver T; Manatsathit W
    S D Med; 2020 Nov; 73(11):528-532. PubMed ID: 33684272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune hepatitis after COVID-19 vaccination.
    Zheng H; Zhang T; Xu Y; Lu X; Sang X
    Front Immunol; 2022; 13():1035073. PubMed ID: 36505482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
    Avci E; Abasiyanik F
    J Autoimmun; 2021 Dec; 125():102745. PubMed ID: 34781161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to: "Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"".
    Bril F; Fettig DM
    J Hepatol; 2021 Oct; 75(4):996-997. PubMed ID: 34146650
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune hepatitis triggered by COVID-19.
    Hong JK; Chopra S; Kahn JA; Kim B; Khemichian S
    Intern Med J; 2021 Jul; 51(7):1182-1183. PubMed ID: 34278694
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    Ghielmetti M; Schaufelberger HD; Mieli-Vergani G; Cerny A; Dayer E; Vergani D; Terziroli Beretta-Piccoli B
    J Autoimmun; 2021 Sep; 123():102706. PubMed ID: 34293683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
    Kang SH; Kim MY; Cho MY; Baik SK
    J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: One or even several swallows do not make a summer.
    Bril F
    J Hepatol; 2021 Nov; 75(5):1256-1257. PubMed ID: 34384822
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune hepatitis or drug-induced autoimmune hepatitis following Covid-19 vaccination?
    Fimiano F; D'Amato D; Gambella A; Marzano A; Saracco GM; Morgando A
    Liver Int; 2022 May; 42(5):1204-1205. PubMed ID: 35230737
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis.
    Kirchner T; Jaeckel E; Falk CS; Eiz-Vesper B; Taubert R
    J Hepatol; 2021 Dec; 75(6):1506-1509. PubMed ID: 34284030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.